生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
ヒト・動物細胞
|
SSP-25(RCB1293)
,
TFK-1(RCB2537)
|
67183
|
Anti-Glypican-1 Antibody-drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1-Positive Cholangiocarcinoma.
|
Mol Cancer Ther |
2021-9-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
|
65682
|
Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC1.
|
J Hematol Oncol |
2017-2-28 |
Pubmed
Full text
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
,
HuH-28(RCB1943)
|
65428
|
Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.
|
Drug Des Devel Ther |
2015-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
SSP-25(RCB1293)
,
HuH-28(RCB1943)
|
61794
|
Lovastatin overcomes gefitinib resistance through TNF-α signaling in human cholangiocarcinomas with different LKB1 statuses in vitro and in vivo.
|
Oncotarget |
2015-9-15 |
Pubmed
Full text
|
ヒト・動物細胞
|
SSP-25(RCB1293)
,
HuCCT1(RCB1960)
|
56128
|
Heteronemin Induces Anti-Proliferation in Cholangiocarcinoma Cells via Inhibiting TGF-β Pathway.
|
Mar Drugs |
2018-12-6 |
Pubmed
Full text
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
,
TFK-1(RCB2537)
|
54909
|
Targeting c-MET by Tivantinib through synergistic activation of JNK/c-jun pathway in cholangiocarcinoma.
|
Cell Death Dis |
2019-3-8 |
Pubmed
Full text
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
,
RBE(RCB1292)
|
54878
|
GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.
|
Invest New Drugs |
2019-12-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Hep G2(RCB1886)
|
54034
|
Angiotensin receptor blockade attenuates cholangiocarcinoma cell growth by inhibiting the oncogenic activity of Yes-associated protein.
|
Cancer Lett |
2018-10-10 |
Pubmed
Full text
|
ヒト・動物細胞
|
TFK-1(RCB2537)
|
52691
|
Combined Gemcitabine and Metronidazole Is a Promising Therapeutic Strategy for Cancer Stem-like Cholangiocarcinoma.
|
Anticancer Res |
2018-5-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
TFK-1(RCB2537)
|
52481
|
A novel photodynamic therapy-based drug delivery system layered on a stent for treating cholangiocarcinoma.
|
Biomed Microdevices |
2017-11-22 |
Pubmed
Full text
|
ヒト・動物細胞
|
TKKK(RCB1907)
|
45038
|
Axitinib (AG-013736), an oral specific VEGFR TKI, shows potential therapeutic utility against cholangiocarcinoma.
|
Jpn J Clin Oncol |
2014-6-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
|
45009
|
Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma.
|
Cancer Sci |
2014-6-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
TKKK(RCB1907)
,
TGBC24TKB(RCB1196)
,
HuCCT1(RCB1960)
|
37684
|
Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma.
|
Br J Cancer |
2009-4-21 |
Pubmed
Full text
|
ヒト・動物細胞
|
HuCCT1(RCB1960)
|
18544
|
Effect of histone deacetylase inhibitor in combination with 5-fluorouracil on pancreas cancer and cholangiocarcinoma cell lines.
|
J Med Invest |
2011-2-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
YSCCC(RCB1549)
,
TKKK(RCB1907)
,
TGBC1TKB(RCB1129)
,
TGBC2TKB(RCB1130)
,
TGBC14TKB(RCB1186)
,
TGBC24TKB(RCB1196)
|
17698
|
Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma.
|
J Hepatobiliary Pancreat Sci |
2011-9-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
YSCCC(RCB1549)
,
HuH-28(RCB1943)
|
17624
|
Potent in vitro and in vivo antitumor activity of sorafenib against human intrahepatic cholangiocarcinoma cells.
|
J Gastroenterol |
2011-6-1 |
Pubmed
Full text
|